AF
NVCR icon

Advisornet Financial’s NovoCure NVCR Stock Holding History

Advisornet Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,300
Closed -$146K – 2328
2025
Q4 		$146K Buy
11,300
+1,600
+16% +$20.5K 0.01% 692
2025
Q3 		$125K Buy
9,700
+5,619
+138% +$75.1K 0.01% 729
2025
Q2 		$72.6K Sell
4,081
-6,385
-61% -$111K ﹤0.01% 862
2025
Q1 		$187K Buy
10,466
+1,500
+17% +$34.1K 0.01% 560
2024
Q4 		$267K Hold
8,966
– – 0.02% 443
2024
Q3 		$140K Buy
8,966
+966
+12% +$17.5K 0.01% 608
2024
Q2 		$137K Buy
8,000
+2,500
+45% +$44K 0.01% 563
2024
Q1 		$86K Buy
5,500
+2,500
+83% +$36.8K 0.01% 670
2023
Q4 		$44.8K Hold
3,000
– – ﹤0.01% 835
2023
Q3 		$48.5K Hold
3,000
– – ﹤0.01% 796
2023
Q2 		$125K Buy
3,000
+800
+36% +$49.7K 0.01% 589
2023
Q1 		$132K Sell
2,200
-10
-0.5% -$799 0.01% 558
2022
Q4 		$162K Buy
2,210
+400
+22% +$30.1K 0.02% 512
2022
Q3 		$138K Hold
1,810
– – 0.01% 581
2022
Q2 		$126K Buy
1,810
+10
+0.6% +$753 0.01% 607
2022
Q1 		$149K Sell
1,800
-5
-0.3% -$368 0.01% 631
2021
Q4 		$136K Buy
1,805
+484
+37% +$48.6K 0.01% 696
2021
Q3 		$153K Hold
1,321
– – 0.01% 664
2021
Q2 		$293K Hold
1,321
– – 0.02% 486
2021
Q1 		$175K Hold
1,321
– – 0.01% 595
2020
Q4 		$229K Buy
1,321
+6
+0.5% +$821 0.02% 469
2020
Q3 		$146K Hold
1,315
– – 0.01% 573
2020
Q2 		$78K Buy
1,315
+1,250
+1,923% +$82.2K 0.01% 744
2020
Q1 		$4K Hold
65
– – ﹤0.01% 1481
2019
Q4 		$5K Buy
+65
New +$5.25K ﹤0.01% 1549

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Advisornet Financial's NVCR Position: Q1 2026 in Review

Advisornet Financial sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 11,300 shares — an estimated $146K sold.

Advisornet Financial first reported a position in NVCR in Q4 2019 and held it in 25 quarters. The position peaked at $293K in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Advisornet Financial reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Advisornet Financial sold 11,300 NovoCure shares in Q1 2026, an estimated $146K.
  • Advisornet Financial first reported a position in NovoCure in Q4 2019 and held it in 25 quarters.
  • Advisornet Financial's NovoCure position peaked at $293K in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.